Nuohong Huikang
Latest round
- Series A
Last raised
- May 2026
Total raised
- $15M
Investors
- 3
About Nuohong Huikang
, trading as Nuohong Huikang, provides biopharmaceutical reagent development and related services for the cell and gene therapy (CGT) and life sciences industry. Nuohong Huikang develops biotechnology products centered on cell biology and CGT upstream reagents, offering solutions including cell culture media, serum substitutes, stem cell and immune cell culture systems, and laboratory reagents, while focusing on high-purity, chemically defined formulations and customizable reagent systems, enabling applications across biomedical research, cell therapy, vaccine and antibody development, diagnostics, and synthetic biology. The company has developed a portfolio of cell culture products for MSC, NK, organoid, and iPSC applications, covering multiple stages of research and industrialization. The company generates revenue primarily through sales of biotechnology reagents and consumables, as well as process development, manufacturing, and technical service offerings for biopharmaceutical clients and research institutions.
Who invested in Nuohong Huikang
3 investors across 1 round
See all investors in Nuohong Huikang
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 25, 2026
Amount
$15M
Investors
Questions about Nuohong Huikang
Who invested in Nuohong Huikang?
Nuohong Huikang has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nuohong Huikang raised?
Nuohong Huikang has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nuohong Huikang last raise money?
Nuohong Huikang's most recent round on record is a Series A, in May 2026.
What does Nuohong Huikang do?
, trading as Nuohong Huikang, provides biopharmaceutical reagent development and related services for the cell and gene therapy (CGT) and life sciences industry.
Where is Nuohong Huikang headquartered?
Nuohong Huikang is headquartered in Chengdu, China.
Which VCs invest in companies like Nuohong Huikang?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Nuohong Huikang's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Nuohong Huikang? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.